I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 5 710 KRW 8.35% Market Closed
Market Cap: 226.6B KRW

Operating Margin
Isu Abxis Co Ltd

24.1%
Current
-4%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.1%
=
Operating Profit
14.3B
/
Revenue
59.4B

Operating Margin Across Competitors

No Stocks Found

Isu Abxis Co Ltd
Glance View

Market Cap
211.6B KRW
Industry
Biotechnology

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Intrinsic Value
6 492.44 KRW
Undervaluation 12%
Intrinsic Value
Price
I
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.1%
=
Operating Profit
14.3B
/
Revenue
59.4B
What is the Operating Margin of Isu Abxis Co Ltd?

Based on Isu Abxis Co Ltd's most recent financial statements, the company has Operating Margin of 24.1%.

Back to Top